UFD1L Antikörper (AA 1-277)
Kurzübersicht für UFD1L Antikörper (AA 1-277) (ABIN1885878)
Target
Alle UFD1L Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-277
-
Aufreinigung
- Purified by antigen-affinity chromatography.
-
Immunogen
- Recombinant protein fragment contain a sequence corresponding to a region within amino acids 1 and 277 of UFD1L
-
-
-
-
Applikationshinweise
-
Suggested dilutions:
Western blotting: 1.500-1.3000
Immunohistochemistry: 1.100-1.500
Immunofluorescence: 1.100-1.200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Konservierungsmittel
- Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- UFD1L (Ubiquitin Fusion Degradation Protein 1 Homolog (UFD1L))
-
Andere Bezeichnung
- UFD1L
-
Hintergrund
-
The protein encoded by this gene forms a complex with two other proteins, NPL4 and VCP, that is necessary for the degradation of ubiquitinated proteins.In addition, this complex controls the disassembly of the mitotic spindle and the formation of a closed nuclear envelope after mitosis.Mutations in this gene have been associated with Catch 22 syndrome as well as cardiac and craniofacial defects.Alternative splicing results in multiple transcript variants encoding different isoforms.[provided by RefSeq]
-
Molekulargewicht
- 35 kDa
-
Gen-ID
- 7353
-
NCBI Accession
- NP_005650, NM_005659
Target
-